AstraZeneca to send direct mail for Toprol-XL

AstraZeneca will send out direct-mail communications as part of a larger campaign for its hypertension drug, Toprol-XL, following reports of name confusion between the treatment and other Rx brands. The overall program launch's audience will include pharmacists and pharmacy technicians, physicians, physician assistants, nurse practitioners, nurses and patients.
You must be a registered member of MMM to post a comment.

Next Article in Pharmaceutical